Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter increased compared to the prior quarter. The reported revenue also rose relative to the same quarter a year earlier.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter increased compared to the prior quarter. The reported revenue also rose relative to the same quarter a year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.2B
Revenue reported for this quarter.
Quarter-over-quarter
+9.8%
Change from the immediately preceding quarter.
Year-over-year
+7.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$44.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 29, 2025 | $10.4B | +0.2% |
| Jun 28, 2025 | $10.9B | +3.0% |
| Sep 27, 2025 | $11.1B | +4.9% |
| Dec 31, 2025 | $12.2B | +7.2% |
Revenue performance
The company reported higher revenue for the quarter, continuing the upward trend observed in recent periods.
Quarterly comparison
Revenue improved from the immediately preceding quarter. Compared with the same quarter one year earlier, revenue was also higher.
What to watch
The filing context discusses tax benefits and interest rate swap impacts, but no specific revenue drivers are cited.